Table 2.
Characteristics of included studies in this systematic review.
Author, year | Age range | Participants (M/F) | Interventions | Frequency and duration of the acupoint injection | Acupoint injection drug, dose | Acupoints injected | Outcomes/measure(s) |
---|---|---|---|---|---|---|---|
Jing, 2013 [26] | 18–75 | 90 (43/47) | EG: Acupoint injection + TDP CG: Acupuncture |
EG: 15 min-2 min/day, once a day or alternate dose, 10 dayS CG: 40 min/day, once a day, 10 dayS |
Cervus and Cucumis Polypeptide injection 4 ml, 0.5–1 ml/point | BL32, BL36, BL40, BL54, BL57, GB37, GB30, SP9, Ashi point | Subjective cure rate |
| |||||||
Li et al., 2004 [23] | 25–75 | 150 (63/87) | EG1: Acupoint injection (2% lidocaine) EG2: Acupoint injection (Danshen injection) CG: Acupuncture |
EG1: Every three days, 20 days EG2: Every three days, 20 days CG: every other day, 20 days |
EG1: 2% lidocaine EG2: Danshen injection |
BL23, BL24, BL25, BL40, GB30, GB34, EX-B05, Ashi point | Subjective cure rate |
| |||||||
Li, 2014 [19] | 22–76 | 100 (59/41) | EG: Acupoint injection + Electroacupuncture CG: Electroacupuncture |
EG: Acupoint injection: Once/5–7 days Electroacupuncture: 25 min one time, once a day, 6 days as a session, 2–4 sessions CG: Electroacupuncture |
2% lidocaine 4 ml + triamcinolone acetonide acetate 12.5 mg + vitamin B12 2 ml | BL23, BL25, BL40, BL54, GV03, Ashi point | Subjective cure rate |
| |||||||
Liu et al., 2012 [35] | Did not report | 208 (did not report) | EG: Acupoint injection + acupuncture CG: Acupuncture |
EG: Acupuncture: 20 min/day, 5 times/week, 2 weeks; acupoint injection: Once a week, 2 weeks CG: 20 min/day, 5 times/week, 2 weeks |
Diprospan 5 mg + mecobalamin 0.5 mg + 0.9% NaCl 10 ml | BL23, BL28, Ashi point | Subjective cure rate |
| |||||||
Luo and Han, 2017 [20] | 23–78 | 80 (65/15) | EG: Acupoint injection + Electroacupuncture. CG: Electroacupuncture | EG: Acupuncture: 25 min/day, 6 times/week, 2–4 weeks; acupoint injection: Once a week, 2–4 weeks CG: 25 min/day, 6 times/week, 2–4 weeks |
2% lidocaine 4 ml + triamcinolone acetonide acetate 12.5 mg + vitamin B12 + 2 ml | BL23, BL25, BL40, BL54, GV03, Ashi point | Subjective cure rate; Patient satisfaction |
| |||||||
Qi, 2012 [21] | 22–78 | 60 (39/21) | EG: Acupoint injection + Electroacupuncture CG: Electroacupuncture |
EG: Acupuncture: 25 min/day, 6 times/week, 2–4 weeks; acupoint injection: once a week, 2–4 weeks CG: 25 min/day, 6 times/week, 2–4 weeks |
2% lidocaine 4 ml + triamcinolone acetonide acetate 12.5 mg + vitamin B1 2.2 ml | BL23, BL25, BL40, BL54, GV03, Ashi point | Subjective cure rate |
| |||||||
Shin et al., 2012 [27] | 18–65 | 60 (27/33) | EG: Acupoint injection CG: sham injection |
EG: Twice a week for 4 weeks for a total of 8 treatment sessions CG: twice a week for 4 weeks for a total of 8 treatment sessions |
EG: In the BVA group, the bee venom was diluted 1 : 2000, and a volume of 0.1 ml was injected into each acupoint. The total injected volume per participant was set at 0.6 ml (0.1 ml × 6 points) CG: Equal amounts of normal saline were injected into each acupoint (0.1 ml × 6 points) |
BL23, BL24, BL25 | VAS, SF-36, ODQ, SLRT |
| |||||||
Wen et al., 2017 [25] | 40–75 | 150 (85/65) | EG: Acupoint injection + function exercise CG: function exercise + voltaren (oral) |
EG: Function exercise: did not report; Acupoint injection: once two days CG: function exercise: did not report; Voltaren (oral): Two pills each time, once a day |
Danhong injection 2 ml each point | GV03, BL23, BL40, BL32 | VAS; subjective cure rate |
| |||||||
Wu et al., 2015 [18] | 24–56 | 93 (52/41) | EG: Acupoint injection + traditional Chinese medicine bone setting technique CG: Lumbar traction |
EG: Acupoint injection: once a day, 20 times as a session; Traditional Chinese medicine bone setting technique: Once every two days, 20 times as a session CG: 15–40 minutes/day |
0.5 mg vitamin B12 (1 ml) + compound Angelica injection (2 ml) + 0.9% NaCl (2 ml) | Back Shu point | Subjective cure rate; VAS |
| |||||||
Yang and Wang, 2010 [24] | Did not report | 90 (did not report) | EG1: Acupoint injection (Angelica injection) EG2: Acupoint injection (O3 injection) CG: Electroacupuncture |
EG1: Once a day, ten times as a session, one session EG2: Once a day, ten times as a session, one session CG: Once a day, ten times as a session, one session |
EG1: Angelica injection (0.5–1 ml) EG2: 1% lidocaine + 30 μg/ml oxygen-ozone 3–5 ml |
BL24, BL25, BL26, Ashi point | Subjective cure rate |
| |||||||
Zhang et al., 2007 [36] | Did not report | 120 (65/55) | EG1: Acupoint injection (Angelica injection) EG2: Acupoint injection (O3 injection) CG: Electroacupuncture |
EG1: Once a day, ten times as a session, one session EG2: Once a day, ten times as a sesson, one session CG: Once a day, ten times as a sesson, one session |
EG1: Angelica injection 0.5–1 ml EG2: 30 μg/ml oxygen-ozone 3–5 ml |
BL24, BL25, BL26, Ashi point | Subjective cure rate |
| |||||||
Zhu, 2003 [22] | 38–72 | 180 (did not report) | EG1: Acupoint injection; EG2: Oral Chinese medicine; CG: The five elements of haci needle + anti-inflammatory agent |
EG1: Once a day, four times as a sesson, one session EG2: Once a day, four times as a sesson, one session CG: 20 minutes/day, once a day, ten times as a session, one session |
Tongxitong 40 mg + Angelica injection 4 ml + vitamin B1 200 mg + vitamin B12 100 mg | GV03, EX-B02, GB34, Ashi point | Subjective cure rate |
VAS, visual analogue scale.